Results for tag: "Stat3 Inhibitors"

Stat3 Inhibitors are a type of oncology drug used to treat cancer. They work by blocking the activity of the Stat3 protein, which is involved in the growth and spread of cancer cells. Stat3 Inhibitors are used in combination with other cancer treatments, such as chemotherapy and radiation therapy, to improve the effectiveness of the treatment. They are also used to reduce the side effects of other treatments. Stat3 Inhibitors are being studied in clinical trials for a variety of cancers, including breast, lung, and colorectal cancer. They are also being studied for their potential to treat other diseases, such as autoimmune disorders and inflammatory diseases. Several companies are developing Stat3 Inhibitors, including Merck, Pfizer, and Novartis. Other companies, such as AstraZeneca, are also researching the potential of Stat3 Inhibitors for the treatment of cancer. Show Less Read more